Trials / Conditions / Recurrent Skin Squamous Cell Carcinoma
Recurrent Skin Squamous Cell Carcinoma
4 registered clinical trials studyying Recurrent Skin Squamous Cell Carcinoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | A PD-1 Checkpoint Inhibitor (Cemiplimab) for High-Risk Localized, Locally Recurrent, or Regionally Advanced Sk NCT04315701 | University of Southern California | Phase 2 |
| Recruiting | Cemiplimab Before and After Surgery for the Treatment of High Risk Cutaneous Squamous Cell Cancer NCT04428671 | Emory University | Phase 1 |
| Terminated | Talimogene Laherparepvec and Panitumumab for the Treatment of Locally Advanced or Metastatic Squamous Cell Car NCT04163952 | Rutgers, The State University of New Jersey | Phase 1 |
| Completed | Erlotinib in Treating Patients With Recurrent or Metastatic Skin Squamous Cell Carcinoma NCT01198028 | M.D. Anderson Cancer Center | Phase 2 |